This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
price-performance: Archive
Mitie Group PLC. (MITFY) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Mitie Group PLC. (MITFY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
MITFYPositive Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in Carrols Restaurant (TAST) is Your Friend, Here's Why
by Zacks Equity Research
Carrols Restaurant (TAST) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
TASTPositive Net Change
price-performance stock-price-change stock-price-movement
Arcos Dorados (ARCO) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Arcos Dorados (ARCO) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
ARCOPositive Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Manitex (MNTX) Should Keep going
by Zacks Equity Research
Manitex (MNTX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
MNTXPositive Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Graham (GHM) Should Keep going
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Graham (GHM) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
GHMPositive Net Change
price-performance stock-price-change stock-price-movement
Earnings Estimates Moving Higher for Monday.com (MNDY): Time to Buy?
by Zacks Equity Research
Monday.com (MNDY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
MNDYPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
What Makes AerCap (AER) a Good Fit for 'Trend Investing'
by Zacks Equity Research
AerCap (AER) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
AERPositive Net Change
price-performance stock-price-change stock-price-movement
Publicis Groupe SA (PUBGY) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Publicis Groupe SA (PUBGY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
PUBGYPositive Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in VirTra, Inc. (VTSI) is Your Friend, Here's Why
by Zacks Equity Research
VirTra, Inc. (VTSI) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
VTSIPositive Net Change
price-performance stock-price-change stock-price-movement
SharkNinja, Inc. (SN) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
SharkNinja, Inc. (SN) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
SNNegative Net Change
price-performance stock-price-change stock-price-movement
What Makes Journey Medical Corporation (DERM) a Good Fit for 'Trend Investing'
by Zacks Equity Research
Journey Medical Corporation (DERM) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
DERMPositive Net Change
price-performance stock-price-change stock-price-movement
Why Instructure (INST) Might be Well Poised for a Surge
by Zacks Equity Research
Instructure (INST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
INSTPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for TowneBank (TOWN) Stock
by Zacks Equity Research
TowneBank (TOWN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
TOWNPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Can Vertex (VERX) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
VERXPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Ceridian (CDAY) Might be Well Poised for a Surge
by Zacks Equity Research
Ceridian (CDAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CDAYPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Fiverr (FVRR) Might be Well Poised for a Surge
by Zacks Equity Research
Fiverr (FVRR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
FVRRPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Leonardo DRS, Inc. (DRS) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Leonardo DRS, Inc. (DRS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
DRSPositive Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Brainsway Ltd. Sponsored ADR (BWAY) Should Keep going
by Zacks Equity Research
Brainsway Ltd. Sponsored ADR (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
BWAYNegative Net Change
price-performance stock-price-change stock-price-movement
Here's What Could Help Knife River (KNF) Maintain Its Recent Price Strength
by Zacks Equity Research
Knife River (KNF) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
KNFPositive Net Change
price-performance stock-price-change stock-price-movement
Here's What Could Help QuickLogic (QUIK) Maintain Its Recent Price Strength
by Zacks Equity Research
QuickLogic (QUIK) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
QUIKPositive Net Change
price-performance stock-price-change stock-price-movement
What Makes Immix Biopharma, Inc. (IMMX) a Good Fit for 'Trend Investing'
by Zacks Equity Research
Immix Biopharma, Inc. (IMMX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
IMMXPositive Net Change
price-performance stock-price-change stock-price-movement
Earnings Estimates Moving Higher for Arch Capital (ACGL): Time to Buy?
by Zacks Equity Research
Arch Capital (ACGL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ACGLPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Dutch Bros (BROS): Time to Buy?
by Zacks Equity Research
Dutch Bros (BROS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
BROSPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Can Erie Indemnity (ERIE) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Erie Indemnity (ERIE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ERIEPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Rising for Abercrombie (ANF): Will It Gain?
by Zacks Equity Research
Abercrombie (ANF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ANFNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank